Pacer Advisors
SNDX icon

Pacer Advisors’s Syndax Pharmaceuticals SNDX Stock Holding History

Pacer Advisors’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,012
Closed -$20.8K – 2685
2024
Q2 		$20.8K Sell
1,012
-722
-42% -$15.1K ﹤0.01% 3425
2024
Q1 		$41.3K Buy
+1,734
New +$38.7K ﹤0.01% 3246
2021
Q2 		– Sell
-3,402
Closed -$76K – 1542
2021
Q1 		$76K Buy
3,402
+866
+34% +$19.6K ﹤0.01% 1340
2020
Q4 		$56K Buy
+2,536
New +$52.6K ﹤0.01% 1406

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return